|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Henry Ford Health System |
|---|---|
| Information provided by: | Henry Ford Health System |
| ClinicalTrials.gov Identifier: | NCT00115284 |
Purpose
The purpose of this study is to determine whether having physicians evaluate their management of certain diseases as part of board recertification results in improved patient care.
| Condition | Intervention |
|---|---|
|
Asthma Health Personnel |
Behavioral: ABIM asthma practice improvement module |
| Study Type: | Interventional |
| Study Design: | Randomized, Single Blind, Active Control, Factorial Assignment |
| Official Title: | An Evaluation of Changes in Physician Performance Through Continuous Professional Development |
| Estimated Enrollment: | 40 |
| Study Start Date: | January 2005 |
| Study Completion Date: | December 2006 |
| Primary Completion Date: | July 2006 (Final data collection date for primary outcome measure) |
In the year 2000, the American Board of Internal Medicine introduced continuous professional development as part of its board recertification process. The purpose of these changes were to achieve the following goals:
The most notable change in the new recertification process was the addition of practice improvement modules (PIMs). These modules require physicians to review how well they manage a particular chronic disease within their practice and to develop an improvement plan for their practice. In April 2005, it became a requirement that all internists complete a PIM as part of board recertification.
Currently, it not known whether having physicians evaluate their management of certain diseases as part of board recertification will achieve its intended goal of improving patient care. Therefore, the purpose of this trial is to assess whether practice improvement modules result in improved clinical performance.
The PIM selected for this study will focus on asthma. As PIMs seek to improve the quality of care within a practice, the unit of randomization in this study will be clinics (i.e., practices) within the Henry Ford Health System. We will enroll practicing, board-certified internists within the Henry Ford Medical Group (~40 internists or 20 per arm). Clinics (~16 or 8 per arm) will then be randomized to either complete the PIM or not complete the PIM. Participating internists at a site randomized to complete the PIM will be encouraged to work together to complete the asthma PIM. Participating internists at control sites will continue usual care and will not be asked to complete an asthma PIM.
Comparisons: We will assess differences in asthma care by prospectively surveying patients seen by physicians in the intervention group and control group following the intervention period. These analyses will be adjusted by the baseline characteristics of asthma patients seen by participating physicians.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, Michigan | |
| Henry Ford Health System | |
| Detroit, Michigan, United States, 48202 | |
| Principal Investigator: | L. Keoki Williams, MD, MPH | Center for Health Services Research, Henry Ford Health System |
More Information
| Study ID Numbers: | F10011 |
| Study First Received: | June 21, 2005 |
| Last Updated: | February 12, 2009 |
| ClinicalTrials.gov Identifier: | NCT00115284 History of Changes |
| Health Authority: | United States: Institutional Review Board |
|
Asthma Education, Medical, Continuing American Board of Internal Medicine |
Recertification Continuous Professional Development Practice improvement |
|
Hypersensitivity Lung Diseases, Obstructive Immune System Diseases Respiratory Tract Diseases Bronchial Diseases |
Lung Diseases Hypersensitivity, Immediate Asthma Respiratory Hypersensitivity |